Demétrio de Souza França, Paula
Guru, Navjot
Roberts, Sheryl
Kossatz, Susanne
Mason, Christian
Abrahão, Marcio
Ghossein, Ronald A.
Patel, Snehal G.
Reiner, Thomas
Funding for this research was provided by:
Foundation for the National Institutes of Health (P30 CA008748)
Article History
Received: 8 February 2020
Accepted: 18 May 2020
First Online: 7 July 2020
Competing interests
: P.D.S.F., N.G., S.R., C.M., M.A. and R.A.G. have no conflicts to declare. S.K., S.P. and T.R. are shareholders of Summit Biomedical Imaging, LLC. S.K., S.P. and T.R. are co-inventors on filed U.S. patent (WO2016164771) that covers methods of use for PARPi-FL. T.R. is co-inventor on U.S. patents (WO2012074840), covering the compositions of matter for PARPi-FL. T.R. is a paid consultant for Theragnostics, Inc. This arrangement has been reviewed and approved by Memorial Sloan Kettering Cancer Center in accordance with its conflict of interest policies.